Global Anti-schizophrenic Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Anti-schizophrenic Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Anti-schizophrenic Drugs by Type
        1.3.1 Overview: Global Anti-schizophrenic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Anti-schizophrenic Drugs Consumption Value Market Share by Type in 2022
        1.3.3 Tablets
        1.3.4 Capsules
        1.3.5 Other
    1.4 Global Anti-schizophrenic Drugs Market by Application
        1.4.1 Overview: Global Anti-schizophrenic Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Other
    1.5 Global Anti-schizophrenic Drugs Market Size & Forecast
    1.6 Global Anti-schizophrenic Drugs Market Size and Forecast by Region
        1.6.1 Global Anti-schizophrenic Drugs Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Anti-schizophrenic Drugs Market Size by Region, (2018-2029)
        1.6.3 North America Anti-schizophrenic Drugs Market Size and Prospect (2018-2029)
        1.6.4 Europe Anti-schizophrenic Drugs Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Anti-schizophrenic Drugs Market Size and Prospect (2018-2029)
        1.6.6 South America Anti-schizophrenic Drugs Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Anti-schizophrenic Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Anti-schizophrenic Drugs Product and Solutions
        2.1.4 Pfizer Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Anti-schizophrenic Drugs Product and Solutions
        2.2.4 Johnson & Johnson Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 AstraZeneca
        2.3.1 AstraZeneca Details
        2.3.2 AstraZeneca Major Business
        2.3.3 AstraZeneca Anti-schizophrenic Drugs Product and Solutions
        2.3.4 AstraZeneca Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 AstraZeneca Recent Developments and Future Plans
    2.4 Eli Lilly
        2.4.1 Eli Lilly Details
        2.4.2 Eli Lilly Major Business
        2.4.3 Eli Lilly Anti-schizophrenic Drugs Product and Solutions
        2.4.4 Eli Lilly Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Eli Lilly Recent Developments and Future Plans
    2.5 Otsuka Pharmaceutical
        2.5.1 Otsuka Pharmaceutical Details
        2.5.2 Otsuka Pharmaceutical Major Business
        2.5.3 Otsuka Pharmaceutical Anti-schizophrenic Drugs Product and Solutions
        2.5.4 Otsuka Pharmaceutical Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Otsuka Pharmaceutical Recent Developments and Future Plans
    2.6 Intra-Cellular Therapies
        2.6.1 Intra-Cellular Therapies Details
        2.6.2 Intra-Cellular Therapies Major Business
        2.6.3 Intra-Cellular Therapies Anti-schizophrenic Drugs Product and Solutions
        2.6.4 Intra-Cellular Therapies Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Intra-Cellular Therapies Recent Developments and Future Plans
    2.7 Sunovion Pharmaceuticals
        2.7.1 Sunovion Pharmaceuticals Details
        2.7.2 Sunovion Pharmaceuticals Major Business
        2.7.3 Sunovion Pharmaceuticals Anti-schizophrenic Drugs Product and Solutions
        2.7.4 Sunovion Pharmaceuticals Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Sunovion Pharmaceuticals Recent Developments and Future Plans
    2.8 Gedeon Richter
        2.8.1 Gedeon Richter Details
        2.8.2 Gedeon Richter Major Business
        2.8.3 Gedeon Richter Anti-schizophrenic Drugs Product and Solutions
        2.8.4 Gedeon Richter Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Gedeon Richter Recent Developments and Future Plans
    2.9 Alkermes
        2.9.1 Alkermes Details
        2.9.2 Alkermes Major Business
        2.9.3 Alkermes Anti-schizophrenic Drugs Product and Solutions
        2.9.4 Alkermes Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Alkermes Recent Developments and Future Plans
    2.10 Indivior 
        2.10.1 Indivior Details
        2.10.2 Indivior Major Business
        2.10.3 Indivior Anti-schizophrenic Drugs Product and Solutions
        2.10.4 Indivior Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Indivior Recent Developments and Future Plans
    2.11 Alexza Pharmaceuticals
        2.11.1 Alexza Pharmaceuticals Details
        2.11.2 Alexza Pharmaceuticals Major Business
        2.11.3 Alexza Pharmaceuticals Anti-schizophrenic Drugs Product and Solutions
        2.11.4 Alexza Pharmaceuticals Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Alexza Pharmaceuticals Recent Developments and Future Plans
    2.12 Noven Pharmaceuticals
        2.12.1 Noven Pharmaceuticals Details
        2.12.2 Noven Pharmaceuticals Major Business
        2.12.3 Noven Pharmaceuticals Anti-schizophrenic Drugs Product and Solutions
        2.12.4 Noven Pharmaceuticals Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Noven Pharmaceuticals Recent Developments and Future Plans
    2.13 Hisamitsu Pharmaceutical
        2.13.1 Hisamitsu Pharmaceutical Details
        2.13.2 Hisamitsu Pharmaceutical Major Business
        2.13.3 Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Product and Solutions
        2.13.4 Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Hisamitsu Pharmaceutical Recent Developments and Future Plans
    2.14 Zhejiang Huahai
        2.14.1 Zhejiang Huahai Details
        2.14.2 Zhejiang Huahai Major Business
        2.14.3 Zhejiang Huahai Anti-schizophrenic Drugs Product and Solutions
        2.14.4 Zhejiang Huahai Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Zhejiang Huahai Recent Developments and Future Plans
    2.15 Chengdu Kanghong Pharmaceutical
        2.15.1 Chengdu Kanghong Pharmaceutical Details
        2.15.2 Chengdu Kanghong Pharmaceutical Major Business
        2.15.3 Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Product and Solutions
        2.15.4 Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Chengdu Kanghong Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Anti-schizophrenic Drugs Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Anti-schizophrenic Drugs by Company Revenue
        3.2.2 Top 3 Anti-schizophrenic Drugs Players Market Share in 2022
        3.2.3 Top 6 Anti-schizophrenic Drugs Players Market Share in 2022
    3.3 Anti-schizophrenic Drugs Market: Overall Company Footprint Analysis
        3.3.1 Anti-schizophrenic Drugs Market: Region Footprint
        3.3.2 Anti-schizophrenic Drugs Market: Company Product Type Footprint
        3.3.3 Anti-schizophrenic Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Anti-schizophrenic Drugs Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Anti-schizophrenic Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Anti-schizophrenic Drugs Consumption Value Market Share by Application (2018-2023)
    5.2 Global Anti-schizophrenic Drugs Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Anti-schizophrenic Drugs Consumption Value by Type (2018-2029)
    6.2 North America Anti-schizophrenic Drugs Consumption Value by Application (2018-2029)
    6.3 North America Anti-schizophrenic Drugs Market Size by Country
        6.3.1 North America Anti-schizophrenic Drugs Consumption Value by Country (2018-2029)
        6.3.2 United States Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        6.3.3 Canada Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        6.3.4 Mexico Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Anti-schizophrenic Drugs Consumption Value by Type (2018-2029)
    7.2 Europe Anti-schizophrenic Drugs Consumption Value by Application (2018-2029)
    7.3 Europe Anti-schizophrenic Drugs Market Size by Country
        7.3.1 Europe Anti-schizophrenic Drugs Consumption Value by Country (2018-2029)
        7.3.2 Germany Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        7.3.3 France Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        7.3.5 Russia Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        7.3.6 Italy Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Anti-schizophrenic Drugs Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Anti-schizophrenic Drugs Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Anti-schizophrenic Drugs Market Size by Region
        8.3.1 Asia-Pacific Anti-schizophrenic Drugs Consumption Value by Region (2018-2029)
        8.3.2 China Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        8.3.3 Japan Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        8.3.4 South Korea Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        8.3.5 India Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        8.3.7 Australia Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Anti-schizophrenic Drugs Consumption Value by Type (2018-2029)
    9.2 South America Anti-schizophrenic Drugs Consumption Value by Application (2018-2029)
    9.3 South America Anti-schizophrenic Drugs Market Size by Country
        9.3.1 South America Anti-schizophrenic Drugs Consumption Value by Country (2018-2029)
        9.3.2 Brazil Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        9.3.3 Argentina Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Anti-schizophrenic Drugs Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Anti-schizophrenic Drugs Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Anti-schizophrenic Drugs Market Size by Country
        10.3.1 Middle East & Africa Anti-schizophrenic Drugs Consumption Value by Country (2018-2029)
        10.3.2 Turkey Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
        10.3.4 UAE Anti-schizophrenic Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Anti-schizophrenic Drugs Market Drivers
    11.2 Anti-schizophrenic Drugs Market Restraints
    11.3 Anti-schizophrenic Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Anti-schizophrenic Drugs Industry Chain
    12.2 Anti-schizophrenic Drugs Upstream Analysis
    12.3 Anti-schizophrenic Drugs Midstream Analysis
    12.4 Anti-schizophrenic Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer